ESC 365 - Controversies in secondary prevention: treating residual risk

ESC Premium Access

Controversies in secondary prevention: treating residual risk

Event: ESC CONGRESS 2019

Topic: Prevention

Session type: Debate Session

Date: 3 September 2019

Time: 14:30 - 15:40

Session

6 presentations in this session

Beyond high intensity statin:drive LDL-C as low as you can - PRO

Speaker: Professor J. Kastelein (Amsterdam, NL)

Beyond high intensity statin:drive LDL-C as low as you can - CON

Speaker: Doctor P. Ridker (Boston, US)

Beyond high intensity statin:drive LDL-C as low as you can - Discussion

Fish oil: it's all about triglycerides - PRO

Speaker: Professor P. Steg (Paris, FR)

Fish oil: it's all about triglycerides - CON

Speaker: Professor J. Armitage (Oxford, GB)

Fish oil: it's all about triglycerides - Discussion

4 speakers from this session

Professor John Kastelein

University of Amsterdam, Amsterdam (Netherlands (The))

20 presentations

1 follower

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

25 presentations

2 followers

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

44 presentations

2 followers

Professor Jane Armitage

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

10 presentations

1 follower

This platform is supported by